Drug Topics
FEBRUARY 5, 2025
ADI-001 is an investigation allogeneic gamma delta chimeric antigen receptor T cell therapy that targets CD20 for the treatment of a variety of autoimmune diseases.
Pharmacy Times
FEBRUARY 5, 2025
The initiative will provide information about care models for specialists and clinical teams to improve patient outcomes in heart failure.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
FEBRUARY 5, 2025
Researchers conducted a population-based study of women in Korea to analyze the association between age at menopause and incidence of type 2 diabetes.
Fierce Healthcare
FEBRUARY 5, 2025
Government unions and cybersecurity experts are disturbed by Elon Musk's newfound access to personal information and the country's payment infrastructure, which coordinates funds for government health programs like Medicare and Medicaid.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
FEBRUARY 5, 2025
Investigators also find that the proportion of patients that were admitted to the intensive care unit after hospital admission was much higher for Black rural patients.
Pharmacy Times
FEBRUARY 5, 2025
The time is right for PBM reform, but the American people might be better served if Congress goes back to the drawing board for a different approach.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
PhRMA
FEBRUARY 5, 2025
One of the largest compounders in the U.S., Hims & Hers, is spending millions of dollars to run a misleading Super Bowl ad that misrepresents their unapproved GLP-1 medicines.
Drug Topics
FEBRUARY 5, 2025
Chelsee Jensen, PharmD, BCPS, senior pharmacy specialist at the Mayo Clinic, discusses key benefits of incorporating biosimilars into a health system's formulary.
PharmaVoice
FEBRUARY 5, 2025
With assets under a knife and pipelines under a microscope, R&D programs are being overhauled to be more efficient and cost effective.
Drug Topics
FEBRUARY 5, 2025
Karissa Kim, PharmD, BCPS, BCACP, discusses the main challenges pharmacists face in assessing and addressing patients health literacy levels.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
FEBRUARY 5, 2025
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Let’s get into all the earnings and political news this week.
Drug Topics
FEBRUARY 5, 2025
Primary hyperoxaluria type 1 (PH1) is a rare genetic condition that affects the kidney, bladder, or urinary tract, and indicates high levels of oxalates in the urine.
pharmaphorum
FEBRUARY 5, 2025
Novo Nordisk is expecting greater competition and pricing pressure in the obesity and diabetes sectors this year.
Pharmacy Times
FEBRUARY 5, 2025
Christian Ruff explains the strong efficacy associated with abelacimab compared with rivaroxaban in the AZALEA-TIMI 71 trial.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
FEBRUARY 5, 2025
Teladoc Health plans to acquire virtual preventive care provider Catapult Health as the company aims to build on its chronic condition management services and expand into at-home testing.
pharmaphorum
FEBRUARY 5, 2025
Robert F Kennedy Jr has cleared a key obstacle in his bid to become the next HHS Secretary after the Senate Finance Committee voted in his favour.
Fierce Healthcare
FEBRUARY 5, 2025
Philadelphia-based Independence Blue Cross has set a benefit exclusion for products that receive accelerated approval from the FDA in most plans. | Philadelphia-based Independence Blue Cross has set a benefit exclusion for products that receive accelerated approval from the FDA in most plans.
pharmaphorum
FEBRUARY 5, 2025
Despite a steep fall-off in sales of RSV vaccine Arexvy last year, GSK has raised its long-term sales forecast to 40 billion in 2031.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
FEBRUARY 5, 2025
Gold bagging integrates health system-owned specialty pharmacies with clinical workflows to enhance safety, efficiency, outcomes, and patient experience.
pharmaphorum
FEBRUARY 5, 2025
The renaissance of Roche's refillable ophthalmic implant Susvimo has continued with FDA approval for use in patients with diabetic macular oedema
Pharmacy Times
FEBRUARY 5, 2025
Diabetic macular edema (DME) is the leading cause of new blindness in the US.
pharmaphorum
FEBRUARY 5, 2025
Liva Healthcare has acquired Momenta to create one of the largest providers of digital healthy lifestyle services to the NHS in England
Pharmacy Times
FEBRUARY 5, 2025
Edward Kim, MD, MBA, highlights the challenges of patient disengagement, data fragmentation, and provider education in precision medicine, emphasizing the need for personalized approaches to enhance patient outcomes, particularly in oncology.
Pharmaceutical Technology
FEBRUARY 5, 2025
X-Elio will supply 245GWh of clean energy annually to four pharmaceutical companies through its Lorca Solar project.
Pharmacy Times
FEBRUARY 5, 2025
An inverse relationship was observed between genetic conditions associated with high levels of low-density lipoprotein cholesterol and the risk of developing T2D.
Pharmaceutical Commerce
FEBRUARY 5, 2025
The company cites a decline in sales and excess inventory as the main contributing factors.
Pharmacy Times
FEBRUARY 5, 2025
Panelists discuss how recent FDA regulatory actions regarding obeticholic acid have raised concerns about its long-term safety profile and accessibility, leading health care teams to develop strategies for supporting patients through treatment transitions while navigating insurance coverage and access challenges for newer primary biliary cholangitis (PBC) therapies.
Pharmaceutical Technology
FEBRUARY 5, 2025
While vaccine sales dropped, GSK raised its revenue guidance for 2031 with speciality medicines expected to drive that growth.
Pharmaceutical Commerce
FEBRUARY 5, 2025
The latest news for pharma industry insiders.
Pharmaceutical Technology
FEBRUARY 5, 2025
Experts at the 2025 Clinical Trial Supply Europe conference will explore supply chain challenges and the impact of AI on trials.
Pharmaceutical Commerce
FEBRUARY 5, 2025
In the first part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Jenna Dale, director of client relations at Cencora, shares how the imposed/pending trade tariffs impact pharma manufacturers.
Pharmaceutical Technology
FEBRUARY 5, 2025
Valnevas chikungunya vaccine Ixchiq has been greenlit by the UKs MHRA, allowing the single-dose vaccine to be made available for adults.
Pharmacy Times
FEBRUARY 5, 2025
Encorafenib in combination with cetuximab and mFOLFOX6 met its dual primary end point of overall response rate of 61%.
Expert insights. Personalized for you.
329 
Let's personalize your content